New Parkinson’s trial platform could “dramatically speed up the search for a cure”

News

Author: Saskia MairPublished: 14 May 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Scientists have proposed the use of a multi-arm, multi-stage trial platform (MAMS) to assess different potential treatments for Parkinson’s and help progress the search for a cure.

This would depart from conventional clinical procedures, allowing several potential treatments to be assessed simultaneously. In a continuous process, each treatment ‘arm’ is evaluated and unsuccessful ‘arms’ of the trial are dropped, enabling a far more cost and time efficient system.

Currently, MAMS are used to evaluate treatments for certain types of cancer – and work is underway to develop MAMS for other neurodegenerative conditions.

Camille Buchholz Carroll, associate professor at the University of Plymouth, UK, and study author, said that MAMS trials could “dramatically speed up the search for a cure”.

She said: “We have the opportunity to learn from the experience in these other conditions and design a new trial that will work for people with Parkinson’s.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.


Read more:

Can higher levels of caffeine and uric acid prevent Parkinson’s?

White blood cells could help diagnose people at risk of Parkinson’s, study finds

Go Back

Share this story

Comments


Related articles


Bas Bloem-US-tour

PD in Practice

The ‘Starbucks formula’: a new approach to Parkinson’s treatment that’s going global

Parkinson’s healthcare scheme where the patient is a partner

READ MORE

Advances

The students breaking ground in Parkinson’s tech

An app that’s digitising the spiral test

READ MORE
A woman sits with her knees up on the edge of her bed.

Special reports

Ask the expert: How does Parkinson’s disease impact dreams?

Dr Daniele Urso shares insights and advice on sleep disturbance

READ MORE